טוען...
Cost-effectiveness of esketamine nasal spray for patients with treatment-resistant depression in the United States
OBJECTIVE: The aim of this study was to estimate the cost-effectiveness of esketamine, a novel intranasally-dosed antidepressant, for patients in the United States with treatment-resistant depression. METHODS: A decision-analytic model, parameterized with efficacy data from phase III randomized tria...
שמור ב:
| הוצא לאור ב: | Psychiatr Serv |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920520/ https://ncbi.nlm.nih.gov/pubmed/32631129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ps.201900625 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|